BofA/Merrill Lynch downgraded Sanofi-Aventis (NYSE: SNY) from Buy to Neutral with a price target of $48.00 after the announcement that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades Management Changes

Jefferies Downgrades Sanofi (SNY) to HoldOctober 29, 2014 8:54 AM Barclays Downgrades Sanofi (SNY) to EqualweightOctober 29, 2014 8:35 AM Deutsche Bank Downgrades Sanofi (SNY) to HoldOctober 29, 2014 8:34 AM Sanofi (SNY) Terminates CEO ViehbacherOctober 29, 2014 6:00 AM